• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Seagen

legos
Biotech

Pfizer taps ex-Novartis leader to helm cancer R&D work

Pfizer is laying down new pieces for its leadership team structure, selecting Novartis' Jeffrey Legos, Ph.D., to serve as chief oncology officer.
Gabrielle Masson Feb 6, 2025 10:45am
100 dollar bills scattered in the air money inflation concept

Pfizer axes B7-H4 ADC, triggering $1B impairment charge

Feb 4, 2025 8:46am
Paraglider over French coast

Biogen boosts C-suite with BMS vet—Chutes & Ladders

Nov 1, 2024 8:30am
theater stage with red curtain and spotlight

Former Seagen CEO unveils new startup Ottimo Pharma

Oct 28, 2024 11:24am
chutes parachutes Turkey

MBX Biosciences, MaaT Pharma and more—Chutes & Ladders

Jun 28, 2024 8:30am
Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings